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Abstract 
Review on TRIB1, with data on DNA, on the protein 
encoded, and where the gene is implicated. 
Keywords 
TRIB1 
Identity 
Other names: C8FW, GIG-2, GIG2, SKIP1 
HGNC (Hugo): TRIB1 
Location 
8q24.13; Transcript (including UTRs) 
chr8:126,442,563-126,450,644 Coding region: 
chr8:126,443,145-126,448,713. 
Note 
The tribbles family of genes encode a group of 
highly conserved pseudokinase proteins, which are 
thought to act as adaptors in several signalling 
pathways that are intimately involved in the 
regulation of a number of key cellular processes, 
including MAPK, and PI3K pathways. Tribbles have 
also been shown to interact with ubiquitin ligases, 
thereby promoting degradation of target proteins. 
Tribbles have been implicated in a number of 
diseases including leukaemia, metabolic syndromes 
and cardiovascular disease.  
Tribbles proteins were first discovered in Drosophila 
as a negative regulator of string/cdc25, where when 
over-expressed directly inhibited mitosis (Grosshans 
and Wieschaus 2000). Simultaneously, TRIBs were 
found to promote the degradation of string via the 
proteasome pathway and showed that 
overexpression of tribbles in  
imaginal disc cells blocked the cell cycle at G2 
resulting in abnormal wing morphology (Mata, et al 
2000). Since then three highly conserved 
mammalian homologues have been indentified; 
Trib1, Trib2 and Trib3. 
DNA/RNA 
Transcription 
There are two protein coding transcripts of TRIB1; 
TRIB1-001 and TRIB1-002. 
TRIB1-001 (Isoform 1); Transcript size: 3,635bp; 
Exon count: 3. 
TRIB1-002 (Isoform 2); Transcript size: 1,332 bp; 
Exon count: 2 
Protein 
Note 
TRIB1-001: 372 amino acids; TRIB1-002: 206 
amino acids 
Description 
TRIB1 contain a N terminal (NT) domain of 60-80 
residues and a C-terminal domain of 35-40 residues 
and a characteristic single central Ser/Thr kinase-like 
(pseudokinase) domain. TRIB1 contains features 
consistent with its emerging role as a protein adaptor 
in signalling pathways. 
N-Terminal Domain The NT fragment of TRIB1  
is proline and serine rich, mostly in the sequence 
adjacent to the kinase-like domain. The abundance 
of these amino acids are a characteristic of PEST 
proteins that are involved in controlling the half life 
of proteins by altering their susceptibility to 
degradation.  
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There are two validated transcripts of TRIB1 (NM_025195 and NM_001282985) coding for isoforms 1 and 2 respectively. 
Isoform 2 has a shorter 5'UTR (untranslated region) and 5' coding region compared to isoform 1 and initiates translation further 
downstream. UTRs and exons are represented by the red and grey boxes respectively. Image drawn by FancyGene (Rambaldi 
and Ciccarelli 2009). 
 
 
Other functions of these types of proteins include the 
anchoring of SH3 or WW domains of other proteins 
or acting as a substrate for proline dependent 
phosphorylation. TRIB1 contains possible 
phosphorylation sites for proline-dependent kinases 
(Hegedus, et al 2007). 
TRIB1 also contains two evolutionary conserved 
motifs. The first consists of a putative nuclear 
localisation signal, [K/R]2X2[D/E]X[D/E]. 
The second motif contains a G-S-P consensus 
pattern found close to the kinase-like domain. The 
G-S-P motif is present in human SNIP1 (Smad 
nuclear interacting protein) which functionally 
associates with BGR1, which interacts with the 
Drosophila homologue of Slbo, C/EBP transcription 
factors (Beausoleil, et al 2004, Kadam, et al 2000). 
C/EBP transcription factors have been shown to 
functionally and physically interact with TRIB1 
promoting their degradation (Yoshida, et al 2013). 
Kinase-like domain TRIB1 contains a Ser/Thr 
kinase-like domain that is composed of some of the 
motifs present in catalytically active kinases such as 
a Lysine crucial for ATP binding whilst others are 
missing. Despite this evidence would suggest TRIB1 
no to possess kinase activity. 
 
Protein structure of Tribbles 1: TRIB1 has a N terminal, pseudokinase and C terminal domains. It contains four protein motifs; a 
putative PEST sequence, a kinase dead catalytic loop, a MEK1 binding and COP1 binding motif. The characteristic amino acid 
sequence for each motif is shown along with location. 
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The tissue specific expression of human TRIB1 mRNA is shown. Data and figure taken from BioGPS. Additional microarray 
expression data from the Human Gene Expression Atlas from the Genomics Institute of the Novartis Research Foundation 
(GNF) can be found on the UCSC browser ( http://genome.ucsc.edu/) (Su, et al 2004, Wu, et al 2009). 
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However this domain is highly conserved during 
evolution suggesting it is important for the role of 
TRIB1(Hegedus, et al 2007). 
C-Terminal Domain The CT domain is around 35-
45 amino acids long and is rich in charged amino 
acids important for protein interactions. Two 
important motifs have been identified in the CT 
domain; a hexapeptide motif [D/E]QXVP[D/E] as a 
COP1 (E3 ubiqutin ligase) binding site, essential for 
proteasome mediated degradation of C/EBPα family 
members and a MEK 1 binding site (ILLHPWF) 
(Hegedus, et al 2007). 
Post translational modifications  Several post 
translational modifications of TRIB1 have been 
reported and validated by mass spectrometry and 
listed in the PhosphoSitePlus database (Hornbeck, et 
al 2012). 
Expression 
TRIB1 expression is ubiquitious with highest 
expression in the thyroid and myeloid cells (Figure). 
TRIB1 is thought to expressed in a cell-type specific 
manner (Sung, et al 2006). 
Localisation 
Numerous over-expression experiments have shown 
TRIB1 to be located in the nucleus. It contains a 
putative nuclear localisation signal (Yokoyama, et al 
2010). 
Function 
TRIB1 has been shown to interact with a number of 
proteins as detailed herein (Table1): 
 MEK-1 and MKK4 Co-immunoprecipitation 
experiments have shown specific interactions with 
MEK1 (an ERK activator MAPKK) and MKK4 (a 
JNK activator MAPKK). Interactions with Tribbles 
control the extent and specificity of MAPK 
activation and are dependent on levels of TRIB 
expression (Kiss-Toth, et al 2004, Sung, et al 2007). 
MEK1 phosphorylates ERK which in turn promotes 
cell proliferation and suppression of apoptosis. The 
interaction between TRIB1 (via ILLHPWF motif) 
and MEK1 
enhances ERK phosphorylation as mutants lacking 
the motif were unable to do so (Yokoyama, et al 
2010) . 
TRIB1 also interacts with MKK4, a JNK activator 
and implicated in the migration and proliferation of 
smooth muscle and involved in the pathogenesis of 
atherosclerosis. The nuclear localisation of TRIB1-
MKK4 complex is dependent on the NT domain of 
TRIB1, however the central kinase-like domain of 
TRIB1 is sufficient for its interaction with MKK4 
but the interaction is no longer preferentially nuclear 
(Sung, et al 2007). 
 COP1 AND C/EBPalpha TRIB1 contains a COP1 
binding site at the carboxy terminus. COP1 is an E3 
ubiquitin ligase that promotes the transfer of 
ubiquitin to target substrates for degradation via the 
proteasome. One of the prinicipal targets of COP1 
are the family of transcription proteins 
CCAT/enhancer binding proteins (C/EBPs). It is 
thought TRIB1 acts to negatively regulate C/EBP 
proteins by acting as adaptors to recruit COP1 to 
C/EBP family members thereby promoting 
ubiquitination and degradation. Studies have shown 
that COP1 requires TRIB1 for its action of C/EBPα 
(Yoshida, et al 2013). 
Homology 
TRIB1 homologues have been indentified in 
different species including mouse, frog and 
zebrafish. Table 2 illustrates some of the TRIB1 
homologues. 
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Table 2: protein and DNA identity of human TRIB1 vs other species. Data taken from Homologene and NCBI. 
 
 
Mutations 
Note 
A somatic point mutation of TRIB1 has been 
reported in Down syndrome (DS)- related acute 
megakaryocytic leukaemia (AMKL) (Yokoyama, et 
al 2012). A G:T point mutation was found in the 
pseudokinase domain resulting in an amino acid 
change from arginine to leucine (R107L). When the 
mutation was expressed in mouse bone marrow cells 
and transferred into lethally irradiated recipient mice 
there was a more rapid development of AML and 
enhancement of ERK phosporylation suggesting a 
gain of function mutation. Yokoyama, et al (2012) 
suggests that the mutation of TRIB1 is an early event 
in leukaemogenesis.  
A wide range of allelic variants of TRIB1 have been 
reported. There are several genetic and protein 
variations of TRIB1 listed on Ensembl.  
Table (3) shows the types of genetic variation of 
TRIB1. Data taken from: 
http://Feb2014.archive.ensembl.org/Homo_sapiens/
Gene/Variation_Gene/Table?db=core;g=ENSG000
00173334;r=8:126442563-126450647 
Protein variants of TRIB1: Table 4 shows the protein 
variants of TRIB1. Each variant is listed in order 
according to residue number. The table also lists 
SIFT and Poly-Phen scores for the variations. SIFT 
predicts whether an amino acid substitution is likely 
to affect protein function based on the sequence 
homology and the physico-chemical similarity 
between the alternate amino acids. Each variant is 
accompanied with a score and predictive  
consequence that is based on the probability that the 
amino acid change is tolerable. A score closer to 0 is 
more likely to be deleterious. A score of <0.05 are 
deleterious and all others are 'tolerated'. PolyPhen 
predicts the effect of an amino acid substitution on 
the structure and function of a protein using 
sequence homology. A PolyPhen score represent the 
probability that a substitution is damaging, scores 
nearer to 1 are more confidently to be predicted to be 
deleterious (opposite to SIFT score). Each score is 
colour coded according to damage (SIFT; Red= 
deleterious, Green= tolerated. PolyPhen; Red= 
probably damaging, Orange= possibly damaging, 
Green= benign) (Adzhubei, et al 2010, Gonzalez-
Perez and Lopez-Bigas 2011, Kumar, et al 2009). 
Data taken from: 
http://Feb2014.archive.ensembl.org/Homo_sapiens/
Transcript/ProtVariations?db=core;g=ENSG000001
73334;r=8:126442563-
126450647;t=ENST00000311922 
Somatic 
See online: Table 4: Protein variants of TRIB1. 
Implicated in 
Smooth muscle cells 
TRIB1 is selectively over-expressed in chronically 
inflamed human atherosclerotic arteries and 
regulates vascular smooth muscle cell (VSMC) 
chemotaxis and proliferation, a characteristic feature 
of atherosclerosis via the JNK pathway (Sung, et al 
2007). 
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Table 3: Genetic variations of TRIB1 
 
Macrophages 
Trib1 is expressed in plaque resident macrophages in 
murine experimental atherosclerosis. The expression 
of Trib1 could be upregulated by IL-1, a major 
contributor to plaque development as the percentage 
of Trib1 expressing macrophages significantly 
decreases in ApoE -/- IL1R-/- double knockout mice 
compared to ApoE-/- controls. Overexpression of 
Trib1 in macrophages in vitro also leads to a 
significant attenuation (~70%) of IL-6 production 
and suppressed IL-12 expression induced with a pro-
inflammatory stimulus (Sung, et al 2012).  
It has also been shown that TRIB1 is involved in 
macrophage migration through interactions with 
C/EBPβ and TNF-a. Knockdown of TRIB1 in 
RAW246.7 cells resulted in an increase in TNF-a 
production and C/EBPβ expression suggesting 
TRIB1 may modulate TNF-a through C/EBPβ (Liu, 
et al 2013).  
Trib1 has been shown to also be involved with 
adipose tissue maintenance and suppression of 
metabolic disorders by controlling the differentiation 
of tissue M2-like macrophages. Trib1 deficiency 
results in a significant reduction of M2-like 
macrophages. Mice lacking Trib1 in haematopoietic 
cells show a reduced adipocyte tissue mass and have 
evidence of increased lipolysis even on a normal 
diet. Supplementation of M2-like macrophages 
causes rescue suggesting the lack of these M2-like 
macrophages are responsible for lipolysis.  
When mice are fed a high fat diet, mice lacking Trib1 
in haematopoietic cells develop 
hypertriglyceridaemia and insulin resistance and a 
pro-inflammatory cytokine induction (Satoh, et al 
2013). 
Cancer 
TRIB1 has been associated with the development of 
cancer and is considered as a leukaemia disease 
gene. It was identified as a collaborator of Hoxa9 and 
Meis1 in myeloid leukaemogenesis (Jin, et al 2007). 
Cooperative genes for Hoxa9/Meis1 were identified 
as common targets for retroviral integration, where 
TRIB1 was identified as the most frequent common 
site for integration in AML (Nakamura 2005). Table 
5 shows the common integration sites and candidate 
cooperative genes in TRIB1-induced AML 
(Yokoyama and Nakamura 2011). TRIB1 alone is a 
transforming gene for myeloid cells and also 
significantly accelerates the development of 
Hoxa9/Meis1 AML. 
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Table 5: Common integration sites and candidate 
cooperative genes in TRIB1-induced AML. 
 
Oncogenesis 
Phosphorylation of ERK is enhanced in TRIB1 
transfected HeLa and Baf3 cells and leukaemia 
cells derived from TRIB1-induced AML upon 
cytokine stimulation (Jin, et al 2007). 
MEK1 and enhancement of MEK/ERK 
phosporylation is required for reactivity. Mutant 
lacking MEK1 binding site is unable to enhance 
phosphorylation of ERK or extend self renewal in 
bone marrow cells or induce AML/accelerate 
Hoxa9/Meis1 induced AML (Yokoyama, et al 
2010). 
TRB1 has been implicated in human AML. TRIB1 is 
found on chromosome 8q24, 1.5Mb away from c-
MYC, the target of AML amplification. TRIB1 is 
over-expressed even in some cases of AML when c-
MYC amplification is not detected (Roethlisberger, 
et al 2007, Storlazzi, et al 2006) 
Cardiovascular Disease and 
Atherosclerosis 
Emerging evidence from several genome-wide 
association studies (GWAS) has implicated TRIB1 
in the risk of cardiovascular disease and events 
specifically due to the levels of circulating lipids 
(Kathiresan, et al 2008, Willer, et al 2008). 
Two SNPs (rs2954029 and rs17321515) near the 
TRIB1 gene have been implicated with triglyceride, 
LDL and HDL levels. A minor G allele at 
rs17321515 was associated with lower triglyceride 
and LDL cholesterol and higher HDL cholesterol 
levels. A TT -> TA -> AA genotypes at rs2954029 
were associated with step wise increases in the 
levels of triglyceride, remnant cholesterol and apo-
lipoprotein B, the primary apolipoproteins present 
on LDLs. Likewise HDL cholesterol levels 
decreased step-wise through the genotypes. 
Additionally the genotypes were found to be 
significantly associated with increased risk of 
ischemic heart disease (IHD) and increased risk of 
MI. 
Further bivariate analysis showed TRIB1 
expression to be significantly associated with 
triglyceride/ elevated blood pressure and 
triglyceride/HDL-cholesterol suggesting TRIB1 
may be involved in a specific feature of lipid 
homeostasis (Kraja, et al 2011). <BR> 
NOTE These genetic studies were further validated 
in in vivo models. Specific hepatic over-expression 
of Trib1 using an adenovirus vector reduced lipid 
plasma levels in a dose-dependent manner due to 
reduced VLDL production. Equally the opposite 
was seen in Trib1- knockout mice due to increased 
VLDL production. Interestingly when hepatic 
expression was reconstituted in knockout mice, 
VLDL-triglyceride production decreased to levels 
found in control mice (Burkhardt, et al 2010). The 
precise mechanisms of Trib1 involvement in lipid 
metabolism however are unknown. <BR> 
NOTE Burkhardt, et al (2010) further investigated 
by examining the mRNA levels of genes associated 
with lipid metabolism in the livers of Trib1 over-
expressing and Trib1- deficient mice. A significant 
decrease was found for genes involved in fatty acid 
oxidation such as Cpt1a (carnitine 
palmitoyltransferase 1A), Cpt2, and Acox1 (acyl-
Coenzyme A oxidase 1) in Trib1 -/- mice. A 
significant up-regulation of key lipogeneic genes 
was also found such as Acc1 (acetyl-Coenzyme A 
carboxylase), fatty acid synthesis (Fasn) and 
stearoyl-Coenzyme A desaturase 1(Scd1). 
Significant downregulation of these genes were 
found in Trib1-over expressing mice. These genes 
have been noted to have effects on VLDL secretion 
and plasma triglyceride and cholesterol levels. 
TRIB1 may also have a further role in lipogenesis. 
TRIB1 over-expression resulted in a significant 
decrease in 35S-methionine labelled apoB secretion 
in HepG2 cells (human liver carcinoma cell line). 
The authors speculate that TRIB1-mediated 
regulation of hepatic lipid availability might alter 
the secretion of apoB particles via a mechanism 
involving ER-associated degradation (ERAD) as 
previous data has shown a reduced availability or 
synthesis of lipid for apoB lipidation leads to co-
translational targeting of apoB for ERAD 
(Ginsberg, et al 2009). 
Type 2 Diabetes 
Trib1 has been hypothesised to have a regulatory 
role in inflammation in adipoctyes that may 
contribute towards obesity related type 2 diabetes. 
Trib1 is specifically up-regulated during acute and 
chronic inflammation in white adipose tissue in 
mice. Trib1 knockout mice show it to be a key 
regulator of inflammatory cytokines such as TNF-a 
and are protected from high fat diet induced obesity 
(Ostertag, et al 2010). It is proposed that Trib1 is 
pro-inflammatory in the adipose by acting as a co-
activator for NF-kB inducing the expression of 
proinflammatory cytokines. 
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